AU2001281880A1 - Use of a formulation made of or containing at least one dissimilated milk serum - Google Patents

Use of a formulation made of or containing at least one dissimilated milk serum

Info

Publication number
AU2001281880A1
AU2001281880A1 AU2001281880A AU8188001A AU2001281880A1 AU 2001281880 A1 AU2001281880 A1 AU 2001281880A1 AU 2001281880 A AU2001281880 A AU 2001281880A AU 8188001 A AU8188001 A AU 8188001A AU 2001281880 A1 AU2001281880 A1 AU 2001281880A1
Authority
AU
Australia
Prior art keywords
milk serum
formulation made
dissimilated
dissimilated milk
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281880A
Other languages
English (en)
Inventor
Ulrich Leithe
Adrianus Mattheus Maria Zijerveld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERICAUSA BV
Original Assignee
SERICAUSA BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERICAUSA BV filed Critical SERICAUSA BV
Publication of AU2001281880A1 publication Critical patent/AU2001281880A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001281880A 2000-06-28 2001-06-25 Use of a formulation made of or containing at least one dissimilated milk serum Abandoned AU2001281880A1 (en)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
DE10031506 2000-06-28
DE10031507 2000-06-28
DE10031505 2000-06-28
DE10031505 2000-06-28
DE10031507 2000-06-28
DE10031504 2000-06-28
DE10031504 2000-06-28
DE10031506 2000-06-28
DE10032243 2000-07-03
DE10032243 2000-07-03
DE10033560 2000-07-11
DE10033560 2000-07-11
DE10033559 2000-07-11
DE10033559 2000-07-11
DE10033558 2000-07-11
DE10033558 2000-07-11
DE10107859 2001-02-20
DE10107859 2001-02-20
PCT/EP2001/007202 WO2002000231A1 (de) 2000-06-28 2001-06-25 Verwendung einer zubereitung aus oder mit einem gehalt an mindestens einem dissimilierten milchserum

Publications (1)

Publication Number Publication Date
AU2001281880A1 true AU2001281880A1 (en) 2002-01-08

Family

ID=27575990

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281880A Abandoned AU2001281880A1 (en) 2000-06-28 2001-06-25 Use of a formulation made of or containing at least one dissimilated milk serum

Country Status (11)

Country Link
US (1) US20030108617A1 (de)
EP (1) EP1296692B1 (de)
JP (1) JP2004501199A (de)
KR (1) KR20030024715A (de)
AT (1) ATE323502T1 (de)
AU (1) AU2001281880A1 (de)
BR (1) BR0112296A (de)
CA (1) CA2412227A1 (de)
DE (1) DE50109557D1 (de)
MX (1) MXPA02012857A (de)
WO (1) WO2002000231A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012319A1 (it) * 2001-11-06 2003-05-06 Mario Baraldi Uso del siero di latte contenente sostanze ad attivita' benzodiazepino-simile
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
IL157814A (en) * 2003-09-08 2007-12-03 Lev Bar Ltd Cosmetic composition comprising camel milk or components thereof
JPWO2006095764A1 (ja) * 2005-03-09 2008-08-14 カルピス株式会社 皮膚における紫外線感受性抑制剤及び機能性飲食品
TW200740378A (en) 2005-06-24 2007-11-01 Calpis Co Ltd Epidermal differentiation and keratinization promoter and functional food and beverage for promoting epidermal keratinization
JP5603537B2 (ja) * 2005-11-28 2014-10-08 源一郎 杣 リポ多糖及びリポ多糖製造方法
GB0605949D0 (en) * 2006-03-24 2006-05-03 Quest Int Serv Bv Milk product for skin treatment
KR100951040B1 (ko) 2007-03-30 2010-04-05 고려대학교 산학협력단 치즈부산물을 함유한 사료조성물을 이용하여 가금류의 알을 생산하는 방법 및 상기 방법으로 생산된 알
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
MY186332A (en) * 2013-07-05 2021-07-10 Yakult Honsha Kk Pentosidine production inhibitor
KR102026366B1 (ko) * 2018-05-11 2019-09-27 주식회사 네이처인랩 복합 프로바이오틱스의 유청 발효물을 포함하는 화장료 조성물, 이의 제조방법 및 이를 포함하는 기능성 화장품

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840670A (en) * 1972-03-01 1974-10-08 Fermented Prod Inc Condensed fermented whey animal feed product and method
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5066491A (en) * 1985-04-15 1991-11-19 Protein Technology, Inc. Method of disease treatment utilizing an immunologically active whey fraction
US5017372A (en) * 1986-04-14 1991-05-21 Medicis Corporation Method of producing antibody-fortified dry whey
US5230902A (en) * 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
DE3827833C1 (de) * 1988-08-17 1989-12-28 Horst 5419 Herschbach De Meinhardt
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
FR2718752B1 (fr) * 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
DE4427705A1 (de) * 1994-08-04 1996-02-08 Herbert Van Lier Pharmazeutisch wirksames, hautschonendes Milchserumbad
US5747031A (en) * 1995-10-05 1998-05-05 Immucell Corporation Process for isolating immunoglobulins in whey
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
WO1998031377A1 (en) * 1997-01-20 1998-07-23 Mohammed Essaidi Use of food products for protection against radicals
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition

Also Published As

Publication number Publication date
EP1296692B1 (de) 2006-04-19
ATE323502T1 (de) 2006-05-15
KR20030024715A (ko) 2003-03-26
DE50109557D1 (de) 2006-05-24
CA2412227A1 (en) 2002-12-11
JP2004501199A (ja) 2004-01-15
BR0112296A (pt) 2003-06-24
EP1296692A1 (de) 2003-04-02
WO2002000231A1 (de) 2002-01-03
MXPA02012857A (es) 2004-07-30
US20030108617A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
WO2001070027A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
CA2395331A1 (en) Pharmaceutical compositions providing enhanced drug concentrations
WO2002056712A3 (en) Highly acidic metalated organic acid as a food additive
NO994722D0 (no) Ernæringsformuleringer inneholdende Lacto-N-neotetraose
BR0116831A (pt) Composição oral e seu uso
AU8979298A (en) Acidic drink
HK1038319A1 (en) Methods and compositions to enhance white blood cell count.
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
WO2002076391A3 (en) Microbial feeds for aquaculture and agriculture
AU2845599A (en) Pharmaceutical compositions and their use
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
BR0210481A (pt) Tablete de caldo de carne compacto
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
BR0210543A (pt) Tablete macio de caldo de carne
CA2085258A1 (en) Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
AU622010B2 (en) Substituted 1,8-naphthyridines
AU1030488A (en) Gamma-glutamyltranspeptidase, its preparation and its use
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
GB0303999D0 (en) Collagen film
WO2001022917A3 (en) Effervescent compositions comprising nimesulide
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
AU2001271088A1 (en) Polyolefin resin composition containing natural antioxidant and thermostabilizerwithout harmful effect to the human body

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application